Proteomics International Laboratories Ltd

ASX:PIQ ISIN:AU000000PIQ0

Proteomics International Laboratories LtdProteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.

 
 

News

Proteomics International Laboratories Ltd (ASX:PIQ) New Endometriosis Test Presented at International Conference

🕔3/24/2023 5:39:04 PM 795

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its potential new world-first blood test for diagnosing endometriosis.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Webinar and Q&A

🕔3/16/2023 5:22:54 PM 1593

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the application for PromarkerD's listing on the Australian Medicare Benefits Schedule hosted by MD, Dr Richard Lipscombe.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) US update - PromarkerD Licensing Negotiations

🕔3/1/2023 9:13:02 AM 2093

Proteomics International Laboratories Ltd (ASX:PIQ) advises that it is in the closing stages of finalising the detailed terms of its Exclusive Licence Agreement with Sonic Healthcare USA for use of the Company's PromarkerD predictive test for diabetic kidney disease in the United States.

Read Full Article

Proteomics International Laboratories Limited (ASX:PIQ) Announce AMA Approval of PromarkerD Test for Diabetic Kidney Disease

🕔1/3/2023 7:48:29 PM 4960

American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease

Read Full Article
###

1,265 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 183) (Last 30 Days: 668) (Since Published: 1265) 

Company Data

    Headquarters
  • QEII Medical Centre
    6 Verdun Street
    Nedlands WA 6009
    Australia
  • Telephone
  • +61-8-9389-1992 
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.proteomics.com.au